Perkin-Elmer Reports Strong Demand For ABI Prism 3700, Updates Celera Progress | GenomeWeb

NORWALK, Conn.--Reflecting continued high demand for genomic products and services, Perkin-Elmer here has reported that revenue for its PE Biosystems division for the first quarter of fiscal 1999 grew 16 percent over the previous year, in part reflecting the introduction of the ABI Prism 3700 DNA Analyzer late in the quarter. Overall the company reported an 8 percent increase in revenue during the period.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.